CT引导微波消融治疗邻近支气管血管束的早期非小细胞肺癌的安全性和局部疗效
回顾性分析231例早期非小细胞肺癌患者CT引导微波消融,其中66个病灶邻近支气管血管束;全组1、2、3年局部无进展生存率分别为77.4%、70.5%、63.8%,邻近支气管血管束组分别为63.0%、50.7%、43.4%;邻近支气管血管束是局部进展的独立危险因素,达到特定消融范围可能提高该类病灶的局部无进展生存率。
要点
- 邻近支气管血管束是早期非小细胞肺癌微波消融后局部进展的独立危险因素。
- 达到特定消融范围(消融区覆盖肿瘤及邻近血管)可能提高邻近支气管血管束病灶的局部无进展生存率。
- 两组术后并发症发生率无显著差异(p > 0.05),最常见为气胸,未发生严重咯血。
核心结论
- 肿瘤邻近支气管血管束是微波消融后局部进展的重要危险因素,达到特定消融范围可能提高该类病灶的局部疗效。
研究设计与样本
- 回顾性研究,纳入231例接受CT引导经皮微波消融的早期非小细胞肺癌患者,其中66个病灶邻近支气管血管束;消融后评估是否达到特定消融范围,比较邻近支气管血管束组与非邻近支气管血管束组的并发症和肿瘤进展。
诊断标准与关键数值
- 特定消融范围定义为消融区覆盖肿瘤及邻近血管。
- 全组1年、2年、3年局部无进展生存率分别为77.4%、70.5%、63.8%。
- 邻近支气管血管束组1年、2年、3年局部无进展生存率分别为63.0%、50.7%、43.4%。
- 多因素分析显示邻近支气管血管束、纯实性肿瘤、肿瘤大小、消融边缘< 5 mm是局部进展的独立危险因素。
- 在邻近支气管血管束组中,血管邻近和特定消融范围失败是局部进展的独立危险因素。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To retrospectively evaluate the safety and efficacy of computed tomography (CT)-guided percutaneous microwave ablation in treating early-stage non-small cell lung cancer (NSCLC) adjacent to bronchovascular bundles.
METHODS: Two hundred and thirty-one patients with early-stage NSCLC who underwent CT-guided microwave ablation of the tumor were included for analysis. Among these, 66 lesions were located adjacent to the bronchovascular bundle. Achievement of the specific ablation range (defined as the ablation zone encompassing the tumor and the adjacent vessel) was assessed after ablation. Complications and tumor progression after treatment were examined and compared between the bronchovascular bundle and non-bronchovascular bundle groups.
RESULTS: A total of 231 patients were included. Overall, 1-, 2-, and 3-year local progression-free survival (LPFS) was 77.4%, 70.5%, and 63.8%, respectively. Bronchovascular bundle proximity, pure-solid tumor, tumor size, and ablation margin < 5 mm were independent risk factors for local progression in multivariate analysis. In the bronchovascular bundle group, the 1-, 2- and 3-year LPFS rates were 63.0%, 50.7%, and 43.4%, respectively; vessel proximity and specific ablation range failure were independent risk factors for local progression. Overall survival in the entire cohort was 93.0% at 1 year, 76.1% at 2 years, and 55.0% at 3 years. The incidence of postoperative complications did not significantly differ between the two groups (p > 0.05). The most common complication was pneumothorax. Severe hemoptysis did not occur.
CONCLUSION: Tumor location near the bronchovascular bundles was a significant risk factor for local progression after microwave ablation. Achieving a specific ablation range may increase LPFS for these lesions.
CLINICAL RELEVANCE STATEMENT: Achieving the specific ablation range may improve local efficacy for early-stage non-small cell lung cancer located adjacent to the bronchovascular bundle.
KEY POINTS: • Local efficacy of percutaneous microwave ablation in treating early-stage non-small cell lung cancer was affected by bronchovascular bundle proximity. • Achieving the specific ablation range may improve local efficacy for lesions located adjacent to the bronchovascular bundle.
引用
- Wang J, Li B, Zhang L, et al. Safety and local efficacy of computed tomography-guided microwave ablation for treating early-stage non-small cell lung cancer adjacent to bronchovascular bundles. Eur Radiol. 2023. PMID: 37505251. doi:10.1007/s00330-023-09997-z
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。